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Summary. [7-3H)Styrene 7,8-oxide was administered by oral gavage to male CD rats at 
a dose of 1.3 mg/kg. After 4 h, the forestomach was excised, DNA was isolated, purified 
to constant specific radioactivity and degraded enzymatically to the 3 '-nucleotides. High-
performance liquid chromatography fractions with the normal nucleotides contained most 
of the radiolabel, but aminute Ievel of adduct Iabel was also detccted. U sing the units of 
thc covalent binding index (micromolcs adduct per mole DNA nucleotide)/(millimole 
chemical administered per kilogram body weight), a DNA binding potency of 1.0 was 
derived. A comparison ofthc covalent binding indices and carcinogenic potencies of other 
genotoxic forestarnach carcinogens showed that the tumorigenic activity of styrene oxide 
is unlikely to be purely genotoxic. Therefore, styrene oxide was compared with 3-t-
butylhydroxyanisole (BHA) with respect to stimulation of cell proliferation in the 
forestomach. Male Fischer 344 rats were treated for four weeks at three dose Ievels of 
styrene oxide (0, 137, 275 and 550 mg/kg, three times per week by oral gavage) and BHA 
(0, 0.5, 1 and 2% in the diet); the highest doses had been reported to result in 84% and 22% 
carcinomas in the forestomach, respectively. Cell proliferation was assessed by 
incorporation of bromodeoxyuridine into DNA and imrnunohistochemical analysis. An 
increase in the labeHing indexwas found in a11 treated animals. In the prefundic region of 
the fore~omach, the labeHing index increased significantly, from 42o/o (controls) to 54o/o 
with styrene oxide and from 41 to 55% with BHA. Rats treated with BHA also had severe 
hyperplastic lesions in the prefundic region, i.e., at the location of BHA-induced forestarnach 
carcinomas. The number of cells per millimetre of section length was increased up to 19 
fold. Hyperplastic lesions were not seen with styrene oxide, despite the higher twnour 
incidence reported with this compound. We conclude that the carcinogenicity of styrene 
oxide to the forestarnach most probably involves a mechanism in which marginal 
genotoxicity is combined with promotion by increased cell proliferation. 
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lntroduction 
Carcinogenesis is a multi-stage process wbich results in an accumulation of a number 
of critical changes in DNA (Harris, 1991). The rate of this process is dependent on the Ievel 
of primary DNA lesions and on the rate ofDNA replication, which can result in fixation of the 
lesions as heritable mutations. Whether a chemical carcinogen affects the first or the second 
aspect is important because the exttapolation to low doses would probably follow different 
rules (Lutz, 1990). While DNA adduct fonnation is expected tobe proportional to dose at the 
lowest Ievels, cell division might not be affected below a certain dose. This question was 
addressed in interpreting the results of bioassays with styrene 7 ,8-oxide. 
Styrene oxide has been investigated for carcinagenicity in several studies in animals: 
After oral gavage, forestarnach tumours were induced in both rats and mice (IARC, 1985; 
Lijinsky, 1986). The genetic toxicology of styrene and styrene oxide has been reviewed 
recently (Barale, 1991). Styrene axide was weakly mutagenic in a number of test systems 
without metabolic activation. DNA adduct formation by styrene oxidein vitro has been 
investigated by Hemminki and coworkers (Vodicka & Hemminki, 1988, and references 
therein). One publication reported the putative identification of a 7 -guanyl adduct in liver 
DNA isolated from mice afterintraperitoneal administration of tritiated styrene and styrene 
oxide (Byfält-Nordqvist et al., 1985). The DNA binding potency tentatively estimated from 
that study and expressed in the units ofthe covalent binding index (CBI) for Ii ver DNA (Lutz, 
1979)-(micromoles adduct per mole DNA nucleotide)/(millimole chemical administered 
perkilogram body weight)-was around 2 for styrene oxide and 2-5 for styrene. This potency 
was higher than expected from the data on genotoxicity in vitro and from the low chemical 
reactivity of styrene oxide (Betso et al., 1991). Reinvestigation of the DNA binding potency 
of styrene oxidein this Iabaratory showed no detectable DNA adduct formation, with a Iimit 
af detection of CBI < 2.6 for forestarnach DNA in the rat (Cantoreggi & Lutz, 1992). 
This study was designed to answer the following questions: (i) whether DNA adduct 
farmation by styrene oxide in the forestarnach could be detected if a lower Iimit of detection 
were achieved, and (ii) whether stimulation of cell division is the mechanistic basis for 
induction of forestomach tumours by styrene oxide. 
Materials and methods 
Styrene oxide-DNA binding 
Chemicals, animals, treatment 
[7-3H]Styrene oxide (103 mCi/mmol) was obtained from the Radiochemical Centre, 
Amersham, United Kingdom. Male Crl:CD®ßR rats from Charles River Wiga, Sulzfeld, 
Germany, were used. Radiolabelied styrene oxide was dissolved in dimethyl sulfoxide and 
corn oil, as described previously (Cantoreggi & Lutz, 1992) and administered to six rats. The 
exact dosewas determined on the basis of the weight ofthe solution administered and is given 
in Table I. 
Isolation of DNA and adduct analysis 
After4 h, forestomachs were excised, pooled into two groups and kept frozen at-20 °C. 
DNA was isolated by chromatin (Sagelsdorff et al., 1983). Repurification ta constant specific 
activity was carried out as reported earlier (Cantoreggi & Lutz, 1992). DNA was digested to 
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constituent deoxyribonucleotides (Sagelsdorff et al . ., 1988), which were separated by high-
performanceliquid chromatography on an Eurosphere RP18 5J.Uß column (250 x 4 mm) with 
2 mVmin 30 mM ammonium formate buffer, pH 3.8 and a 2--60% methanol gradient system 
(Cantoreggi & LutzJ 1992). The radiolabet attributable to adducts was converted toCBI units. 
Cell division in the forestomach after exposures to styrene oxide and BHA 
Application solutions and food 
Solutions of styrene oxide (purity, > 98%; Merck) were prepared in com oil (Kentaur-
Nuxo,Burgdorf,Switzerland).3-t-Butyl-4-hydroxyanisole(BHA;purity,> 98%)wasobtained 
from Fluka (Buchs SG, Switzerland) and cereal-based maintenance diet (#890) in pellets and 
powder form from Nafag (Gossau SG, Switzerland). The appropriate amounts ofBHA (e.g., 
60 g for the 2% diet) weredissolved in 100 ml diethyl ether andpoured onto400 g powdered 
food. A homogeneous slurry was prepared, and the ether was evaporated under ambient air 
for 60 h. The premix was pulverized in a mortar and mixed for 0.5 hin a food-mixing machine 
to make up a total of 3 kg. 
Animals and treatments 
Forty seven-week-old male Fischer 344 rats from Charles River Wiga were held in 
groups of five. Those exposed to styrene oxide received pelleted dietat all times, whereas 
those treated with BHA were switched to powdered food after one week of acclimatization. 
During the four-week treatment period, rats were administered styrene oxide at 0, 137, 275 
or 550 mg/kg by oral gavage in com oil (1 ml solution per kg bw), three times per week (on 
Monday, W ednesday and Friday at 8:00 h). The concentrations of BHA in powdered food 
were 0, 0.5, 1 and 2%. 
On Monday of week 5, after a final treatment with styrene oxide, Atzet osmotic 
minipumps (Model 20010, Lot 04 7001, flow rate 9.1 JJ.l/h, one-day delivery; Alza Corp., 
Palo Alto, CA, USA) filled with 220 ~ bromodeoxyuridine {BrdU) (Sigma) solution (20 mg/ 
ml BrdU, 10 mM potassium phosphate, 130 mM sodium chloride, pH 7 .6, and 1% 1 N 
sodium hydroxide) were implanted subcutaneously in the upper back of the mts in the early 
aftemoon. 
Histopathology and immunohistochemistry 
After 24 h, the stomach was excised, cut open along the minor curvature, rinsed in 0.9% 
aqueous sodium chloride, pinned flat on a cork board and fixed in buffered fonnalin for one 
week. A 3-mm thick suip was cut along the major curvature, embedded in Paraplastparaffin 
(Monoject Scientific Inc., Athy, Ireland) and cut into 2-J.UD-thin sections. 
The sections were stained immunohistochemically for incorporation ofBrdU into DNA 
(Dietrich & Swenberg, 1991). A monoclonal primary antibody (anti-BrdU murine 
immunoglobulin G; Becton Dickinsan Co., Research Triangle Park, NC, USA) was linked 
with a secondary antibody (biotinylated goat anti-mouse immunoglobulin 0) to a labet 
(stteptavidin) coupled with alkaline phosphatase. Fast red was used as the chromogen. Link 
and Iabel were components of a 'Supersensitive Kit' purchased from BioGenex Laboratories 
lnc. (San Ramon, CA. USA). The sections were counterstained with haematoxylin. 
Assessment of cell munbers and labelling index 
BrdU-positive cells bad red nuclei; the negative nuclei stained blue. Cells (220 on 
average) were counted in tbree defined anatomical regions of the forestomach: the saccus 
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caecus (near the oesophagus ), the midregion and the prefundic region (near the limiting ridge 
with the glandular stomach). Only the cells in the basal, cohesive layers were counted. The 
total number of cells per millimetre section length (1), the number of dividing cells per 
millimetre section length (2) and the labeHing index, the ratio of (2):(1), were determined. 
One section was evaluated per rat. An average was calculated for the groups of five rats and 
expressedas mean ± 1 SD. Differences between the groups were analysed using a two-sided 
Fisher test. 
Results 
Styrene oxide-DNA binding 
Forestomach DNA samples isolated from treated animals showed a constant specific 
radioactivity after one round ofrepurification (Table 1). Radiolabel irreversibly associated 
with DNA is not necessarily due to nucleotide-carcinogen adduct formation but can be 
the result of biosynthetic incorporation of radrolabel durlog DNA biosynthesis. With 
[7-3H]styrene oxide, for instance, tritiated water is formed during metabolism. Tritium from 
water can be incorporated into the 2 '-position of the deoxyribose in the ribonucleotide 
reductase step. In order to distinguish true adduct formation from biosynthetic radiolabet 
incorporation, nucleotides were analysed for radiolabel. 
Table 1. Covalent binding of [7-3H]styrene 7,8-oxide (SO) to forestomach DNA of male CD rats 
after oral administration 
Rat Dose DNA specific activity Nudeotide analysis CBI 
no. 
mglkg 1()9 (dpm'mg)* Radiolabel Radiolabel SO-nudeo- uni1s 
dprn'kg 1st purifi- 2nd purifi- recovered withoutOO tiefe adduds 
cation cation 
1 1.41 2.67 
2 1.37 2.60 51 ±8 45±9 
3 1.25 2.39 
600/o 3gok 8.2dpmlmg 1.0 
4 1.28 2.44 
5 1.24 2.38 33±8 25±8 
6 1.25 2.39 
00, optical density; ± 2 SO from the statistical counting error 
High-performance liquid chromatography proFlies of nucleotides showed that most of 
the radiolabel eluted with the normal nucleotides. A small but significant amount of 
radiolabet was detected at elution times similar to those of the early-eluting styrene-
nucleotide adducts (Cantoreggi & Lutz, 1992). When expressedas CBI, the DNA binding 
potency was at the low Ievel of 1.0. 
Effects of styrene oxide and BHA on tbe forestomach 
Histopathology 
In the styrene oxide-tteated rats, a marginal increase in the thickness of the squamous 
epithelium and slightly enhanced keratinization were observed. Two animals, one in. the 
intermediate- and one in the high-dose group, showed mild hyperplasia in the midregion. 
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BHA treatment resulted in a dose-dependent increase in the nwnber and severity of 
histopathological lesions in the forestomach. At a dose of 0.5% BHA, there was mild 
hyperkeratinization and increased thicknessofthe squamous epitheliallayer. One animal had 
a mildly hyperplastic lesion near the limiting ridge. All animals treated with I% BHA showed 
squamous epithelial hyperplasia and hyperkeratosis near the limiting ridge~ while few 
animals had hyperplastic lesions in the midregion ofthe forestomach. No lesion was observed 
in the saccus caecus. V arious degrees of hyperplasia were seen in all rats in the group tteated 
with 2% BHA; in one case, possibly a papilloma was seen near the limiting ridge. In three 
animals, mild hyperplastic lesions were found in the midregion of the forestomach. 
Hyperkeratinization was evident in all three anatomical regions ofthe forestomach, although 
it was mostextensive near the limiting ridge and in the midregion. 
Labelling index 
The four-week exposure ofrats to both styrene oxide and BHA significantly increased 
the rate of proliferation in all regions of the forestomach (Table 2). No clear dose-response 
relationship was seen, indicating that the cell proliferation response had reached its 
biological maximum when measured as an integral over 24 h. Styrene oxide and BHA had 
similar effects. The markedly different pathological findings were not reflected by the 
labeHing index. 
Table 2. LabeJUngindex (BrdU-positive cells dividad by total cells x 100) in the basal-eeil 
layers in three regions of the forestomach of male Fischer 344 rats exposed by oral gavage 
to styrene 7 ,8-oxide (three times per week for four weeks) and 3-t-butyl-4-hydroxyanisole 
(BHA) in the diet for four weeks (mean ± 1 SD) 
Foresternach Styrene oxide dose (mglkg) BHA ooncentration in diet f/o) 
region 
0 137 275 550 0 0.5 1 2 
Saccus caews 49±8 61±6** 70±5*** 70±4*** 37±7 50±10** 53±10** 51±9* 
Midregion 43±1 63±8*** 63±7*** 59±5*** 43±7 66±4**'* 56±14* 60±15** 
Prefundc region 42±8 47±9 55±9'* 54±11* 41±6 62±8*** 66f8*** 55:tB** 
Differences from contro1 group (two-sided Fisher test): •, p < 0.05; ••, p < 0.025; •••, p < 0.0025 
Quantijication of hyperplasia 
As the Jabelling index did not indicateregional differences, yet pathological observations 
correlated with tumour location after BHA treatment, additional variables were investigated 
for a quantitative description of the hyperplastic response of the forestomach to BHA. The 
total number of cells per millimetre section length is shown in Figure 1. In rats given styrene 
oxide, this number was constant, in agreement with the Iack of site specificity of the (minor) 
histopathological findings. Dietary exposure to BHA, however, caused a dramatic increase, 
mostly in the prefundic region, in the number of cells per unit section length. At the lowest 
dose (0.5% ), two of five animals showed a three-fold increase in the nurober of cells per 
millimetre section length in the prefundic region of the forestomach. No hyperplastic effect 
was seen in the saccus caecus or in the midregion. With 1% BHA, all animals showed a 
marked increase in the number ofcells in the preflDldic region; in the group given 2%, the 
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effect was even more dramatic, and one animal bad a 19-fold increase in the nurober of cells 
per millimetre over that in controls. The saccus caecus region was still not affected. 
Ftgure 1. Number of cells per millimetre section length in three regions of the torestornach 
of male Fischer 344 rats exposed to styrene oxide (A) by oral gavage (three times per week 
for four weeks) and 3-t-butyl-4-hydroxyanisole (BHA; 8) at 0-2% in the diet for four weeks. 
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Discussion 
DNA binding potency of styrene oxide and genotoxic carcinogenesis 
Styrene oxidewas shown to have low DNA binding potency in the forestomach ofrats, 
with a CBI of 1.0. This low genotoxic potency is in concordance with the weak mutagenicity 
of styrene oxide (Barale, 1991) and with its poorreactivity towards DNA in vitro (Cantoreggi 
& Lutz, 1992). 
Styrene had a CBI of only 0.1 in mouse liverandrat lung after exposure by inhalation 
(Cantoreggi & Lutz, 1993), although styrene is metabolized almost completely to styrene 
oxide. The 10-fold greater DNA binding potency of styrene oxidein the forestarnach is the 
result of a high local concentration of the compound at the site of administration. 
The aim of this study was to investigate whether DNA binding is responsible for the 
tumorigenic response observed. This goal can be accomplished by comparing the CBI of 
styrene oxide with those of other forestomach carcinogens. For instance, 1 ,2-d.ichlorethane 
produced forestarnach tumours in rats after administration by oral gavage, with a carcinogenic 
potency similar tothat of styrene oxide (Gold et al., 1991). Reitz et al. (1982) showed that 
I ,2-dichlorethane has a CBI of7 in the stomach, i.e., a DNA binding potency more than seven 
times that of styrene oxide. This finding may be a frrst indication that a purely genotoxic 
mechanism for the tumorigenic action of styrene oxide in the forestomach is unlikel y. 
Effects of styrene oxide and BHA on tbe torestornach 
The two forestomach carcinogens, styrene oxide and BHA, showed different dose-
response relationships for cancer induction. At the highest dose Ievel used in both the 
bioassays and the present study, styrene oxide induced squamous-cell carcinomas in male 
rats at an incidence of 84% (Lijinsky., 1986); BHA induced an incidence of 22% (Ito et al., 
1986). At one-half ofthat dose, styrene oxidestill induced forestomach carcinomas in 67% 
of the rats, whereas BHA induced benign lesions only. On the basis of this dose-effect 
relationship, we would have expected a generally stronger response in the styrene oxide-
treatedanimals, but, withrespecttohyperplasiaandthenumberofcells 'atrisk'., theopposite 
was true: BHA was much more effective. Additional mechanisms of action must be operating 
in the induction of the high incidence of carcinomas by styrene oxide. In view of its mutagenic 
activity and of the DNA binding detected in this study, genotoxicity is a reasonable 
explanation. The high incidence of forestomach tumours is therefore probably due to a 
combination of DNA adduct formation and an enhanced rate of cell proliferation. 
If this combination resulted in multipJicative synergism of genotoxic and epigenetic 
mechanisms, it would also affect the shape of the dose-response curve: The Ievel of DNA 
darnage would be expected to decrease in proportion to decreasing dose. For cell division, 
however, no increase would be expected at dose Ievels that no Ionger result in Stimulation of 
cell division, resulting in non-linearity for forestomach tumours induced by low doses of 
styrene oxide. Under such circumstances, estimates of carcinogenic potency derived from 
exposures at high dose Ievels should not be used to predict the effects oflow-Ievel exposures. 
251 
Lutz et al. 
References 
Barale, R. (1991) The genetic toxicology of styrene and styrene oxide. Mutat. Res., 257, 107-126 
Betso, J.E., Carreon., R.E. & Miner, V.M. (1991) The use of proton nuclear rnagnetic resonance 
spectrometry (lH NMR) for monitaring the reaction of epoxides with butylamine and predictive 
capahililies of the relative alkylation index (RAI) for skin sensitization by epoxides. Toxicol. 
Appl. Pharnwcol., 108,483-488 
Byfält-Nordqvist, M., Löf, A., Osterman·Golkar, S. & Walles, S.A.S. (1985) Covalent binding of 
styrene and styrene 7 ,8-oxide to plasma proteins, hemoglobin and DNA in the mouse. Chem.-
Biol.lnteractions., 55, 63-73 
Cantoreggi, S. & Lut~ W.K. (1992) lnvestigation ofthe covalent binding of styrene-7,8-oxide to DNA 
in rat and mouse. Carcinogenesis, 13, 193-197 
Cantoreggi,S.&Lutz, W.K.(1993)Covalentbind.ingofstyrenetoDNAinratandmouse.Carcinogenesis, 
14,355-360 
Dietrich, D.R. & Swenberg, I.A. (1991) The presenceof alpha-2J.L-globulin is necessary ford-limonene 
promotion of male rat kidney tumors. Cancer Res., 51, 3512-3521 
Gold, L.S., Slone, T.H., Manley,N.B., Garfmkel, G.B., Hudes, E.S., Rohrbach, L. & Ames, B.N. (1991) 
The Carcinogenic Potency Database: analyses of 4000 chronic animal cancer experirnents 
published in the generalliterature and by the US National Cancer Institute/National Toxicology 
Prograrn. Environ. Health Perspectives, 96, 11-15 
Harris, C.C. (1991) Chemical and physical carcinogenesis: advances and perspectives for the 1990s. 
Cancer Res., 51, 5023s-5044s 
IARC (1985) IARC MotWgraphs on the EvaluaJion ofthe Carcinogenic Risk ofChemica./s to Hun:uvzs, 
Vol. 36, Allyl Compounds~ Aldehydes, Epoxidesand Peroxides, Lyon, pp. 245-263 
lto, N., Fukushima, S., Tamano, S., Hirose, M. & Hagiwara, A. (1986) Doseresponse in butylated 
hydroxyanisole induction of forestarnach carcinogenesis in F344 rats. J. Narl Cancer lnst., 77, 
1261-1265 
Lijinsky, W. (1986) Rat and mouse forestomach tumors induced by chronic oral administration of 
styrene oxide. J. Natl Cancer Inst., 77, 471-476 
Lutz, W.K. (1979) In vivo covalent binding of organic chemieals to DNA as a quantitative indicator in 
the process of chemical carcinogenesis. Mutat. Res., 65, 289-356 
Lutz, W .K. ( 1990) Doseresponse relationship and low dose extrapolation in chemical carcinogenesis. 
Carcinogenesi~ 11, 1243-1247 
Reit~ R.H., Fox, T.R., Ramsey, J.C., Quast, J.F., Langvard~ P.W. & Watanabe, P.G. (1982) 
Pharmacokinetics and macromolecular interactions of ethy lene dichloridein rats after inhalation 
or gavage. Toxicol. Appl. Pharmacol., 62, 190-204 
Sagelsdorff, P., Lutz, W.K. & Schlatter, C. (1983) The relevance of covalent binding to mouse liver 
DN A to the carcinogenic action of hexachlorocyclohexane isomers. C arcinogenesis, 4, 1267-
1273 
Sagelsdorff, P., Lut~ W.K. & Schlatter, C. (1988) DNA methylation in rat liver by diaminozide, 1,1-
dimethylhydrazine, and dimethylnitrosamine. Fundam. Appl. Toxicol., 11, 723-730 
Vodicka, P. & Hemminki, K. (1988) Identification of alkylation products of styrene oxidein single- and 
double-stranded DNA. Carcinogenesis., 9, 1657-1660 
Note added in proof: 
A full description of the study of cell proliferation has appeared in Cancer Research, 53, 3505-
3508 (1993): lnduction of cell proliferation in the forestomach of F344 rats following subchronic 
administrationofstyrene 7,8-oxide and butylatedhydroxyanisole, by S. Cantoreggi, D.R. Dietrich and 
W.K. Lutz. 
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